Avet Pharmaceuticals, Inc. is recalling 21,968 bottles of Tetracycline HCl Capsules (250 mg and 500 mg strengths) because they failed dissolution testing during long-term storage evaluations. This means the medication may not dissolve properly in the body as intended. If the drug does not dissolve correctly, the patient may not absorb the necessary amount of the antibiotic to effectively treat their infection. Consumers who have these capsules should contact their healthcare provider or pharmacist, as the medication's effectiveness may be compromised.
When a drug fails dissolution specifications, it may not release its active ingredient at the correct rate or amount. This can lead to lower-than-intended blood levels of the antibiotic, potentially resulting in treatment failure for bacterial infections or the development of antibiotic resistance.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.